Siga Technologies (SIGA) Capital Expenditures Growth (3y) (2013 - 2024)
Powered by 
Analysis
Siga Technologies (SIGA) Capital Expenditures Growth (3y) (2013 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 5.53% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 21.85% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -2.55% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -12.57% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -16.45% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 19.16% |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 34.19% |
| 10 | Siga Technologies | 235.60 Mn | 80.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -12.02% |
| Jun 30, 2024 | -41.11% |
| Dec 31, 2021 | -29.39% |
| Jun 30, 2021 | -27.31% |
| Dec 31, 2019 | -94.63% |
| Sep 30, 2019 | 2,621.01% |
| Jun 30, 2019 | -26.02% |
| Mar 31, 2019 | 1.84% |
| Dec 31, 2018 | 17.57% |
| Dec 31, 2017 | 177.29% |
| Jun 30, 2017 | 49.75% |
| Dec 31, 2016 | -64.52% |
| Sep 30, 2016 | -25.99% |
| Jun 30, 2016 | -69.62% |
| Mar 31, 2016 | -68.40% |
| Dec 31, 2015 | -47.95% |
| Sep 30, 2015 | 51.22% |
| Dec 31, 2014 | -74.07% |
| Jun 30, 2014 | -39.11% |
| Mar 31, 2014 | -31.18% |